Reversion of resistance of human gastric cancer cell line SGC7901/DDP to cisplatin by amiRNA-snail and its possible mechanism

Chinese Journal of Gastroenterology

Volumn 17, Issue 3, 2012, Pages 146-150

  Xu, Chunhong ^a   Guo, Huimin ^b   Wang, Jun ^b   Li, Jianqi ^b   Chen, Min ^b   Zou, Xiaoping ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

^b MEDICAL SCHOOL OF NANJING UNIVERSITY   (China)

Author keywords

Cadherins; Cell line, tumor; Drug resistance; Epithelial mesenchymal transition; RNA interference; Snail; Stomach neoplasms

Indexed keywords

ARTIFICIAL MICRORNA SNAIL; CHOLECYSTOKININ OCTAPEPTIDE; CISPLATIN; EXCISION REPAIR CROSS COMPLEMENTING PROTEIN 1; MICRORNA; TRANSCRIPTION FACTOR SNAIL; UNCLASSIFIED DRUG; UVOMORULIN;

ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CANCER RESISTANCE; CELL SURVIVAL; CHEMOSENSITIVITY; CONTROLLED STUDY; DOWN REGULATION; FLUORESCENCE; GENE CONSTRUCT; GENE SILENCING; GENE TARGETING; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IC 50; IMMUNOFLUORESCENCE; NONVIRAL GENE THERAPY; PLASMID; PROTEIN EXPRESSION; STOMACH CANCER; SURVIVAL RATE; UPREGULATION; WESTERN BLOTTING;

EID: 84861763979     PISSN: 10087125     EISSN: None     Source Type: Journal    
DOI: 10.3969/j.issn.1008-7125.2012.03.004     Document Type: Article

References (13)

1. Nieto M A. The snail superfamily of zinc-finger transcription factors[J]. Nat Rev Mol Cell Biol, 2002, 3 (3): 155-166.
2. Cano A, Pérez-Moreno M A, Rodrigo I, et al. The transcription factor snail controls epithelial-mesenchymal transitions by repressing E-cadherin expression[J]. Nat Cell Biol, 2000, 2 (2): 76-83.
3. Medici D, Hay E D, Olsen B R. Snail and Slug promote epithelial-mesenchymal transition through beta-catenin-T-cell factor-4-dependent expression of transforming growth factor-beta3[J]. Mol Biol Cell, 2008, 19 (11): 4875-4887.
4. Haslehurst A M, Koti M, Dharsee M, et al. EMT transcription factors snail and slug directly contribute to cisplatin resistance in ovarian cancer[J]. BMC Cancer, 2012, 12 (1): 91.
5. Arumugam T, Ramachandran V, Fournier K F, et al. Epithelial to mesenchymal transition contributes to drug resistance in pancreatic cancer[J]. Cancer Res, 2009, 69 (14): 5820-5828.
6. Saxena M, Stephens M A, Pathak H, et al. Transcription factors that mediate epithelial-mesenchymal transition lead to multidrug resistance by upregulating ABC transporters[J]. Cell Death Dis, 2011, 2 (7): e179.
7. Thiery J P. Epithelial-mesenchymal transitions in tumour progression[J]. Nat Rev Cancer, 2002, 2 (6): 442-454.
8. Shah A N, Summy J M, Zhang J, et al. Development and characterization of gemcitabine-resistant pancreatic tumor cells[J]. Ann Surg Oncol, 2007, 14 (12): 3629-3637.
9. Rosano L, Cianfrocca R, Spinella F, et al. Acquisition of chemoresistance and EMT phenotype is linked with activation of the endothelin A receptor pathway in ovarian carcinoma cells[J]. Clin Cancer Res, 2011, 17 (8): 2350-2360.
10. Işeri O D, Kars M D, Arpaci F, et al. Drug resistant MCF-7 cells exhibit epithelial-mesenchymal transition gene expression pattern[J]. Biomed Pharmacother, 2011, 65 (1): 40-45.
11. Chen X, Wang Y, Xia H, et al. Loss of E-cadherin promotes the growth, invasion and drug resistance of colorectal cancer cells and is associated with liver metastasis[J]. Mol Biol Rep. 2012 Feb 7. Epub ahead of print.
12. Li Q, Dang C X, Liu Z G, et al. ERCC1 expression is a predictor of survival in gastric cancer patients treated with surgery and adjuvant chemotherapy[J]. Chinese-German Journal of Clinical Oncology, 2011, 10 (2): 92-95.
13. Hsu D S, Lan H Y, Huang C H, et al. Regulation of excision repair cross-complementation group 1 by Snail contributes to cisplatin resistance in head and neck cancer[J]. Clin Cancer Res, 2010, 16 (18): 4561-4571.